Medtronic received information via literature regarding comparison of surgical and transcatheter pulmonary valve implants over a 20-year period.All data were collected from a single center between august 1998 to april 2020.The study population included a total of 493 patients (predominantly male, mean age 26.3 years, mean weight 67.1 kg) with 365 patients in the surgical group and 128 patients in the transcatheter group.Multiple manufacturer¿s devices were implanted in the study population.Among all patients 80 were implanted with a medtronic device: in the surgical group 14 received a hancock aortic valve and 2 received a medtronic contegra conduit, and in the transcatheter group 64 received a melody bioprosthetic valve.No unique device identifier numbers were provided for these devices.Among all patients, 4 deaths (4 surgical and 0 transcatheter) occurred within 30 days and 22 deaths (16 surgical and 6 transcatheter) occurred during the follow-up period.Based on the available information medtronic product was not directly associated with the death(s).Among patients in the surgical group, adverse events included: endocarditis (median time 13 months post-implant), sternal infection/ dehiscence, mediastinal hematoma, pericardial effusion requiring pericardiocentesis, iatrogenic ventricular injury requiring pericardial patch, coronary artery injury requiring intraoperative repair, postoperative hypotension, right ventricular outflow tract (rvot ) obstruction due to rotation of pulmonary valve requiring valve explant, bradycardia requiring permanent pacemaker implant, postoperative stroke, high pressure gradients (25.4 mmhg), and severe pulmonary regurgitation.Based on the available information medtronic product may have been associated with the adverse event(s).Among patients in the transcatheter group, adverse events included: endocarditis (melody median time 27.5 months post-implant), sternal pulmonary edema, rvot conduit rupture, valve embolization, hematoma, high pressure gradients (26.9 mmhg), and moderate pulmonary regurgitation.Based on the available information medtronic product may have been associated with the adverse event(s).Based on the available information medtronic product may have been associated with the adverse event(s).No additional adverse patient effects or product performance issues were reported.
|